Resources
Press Release, 13 April 2021
Kuros Biosciences treats first patient in clinical trial of MagnetOs Putty for posterolateral spine fusion
Press Release, 08 April 2021
Kuros Biosciences announces treatment of first patient in Australia with MagnetOs for spine fusion
Press Release, 06 April 2021
Kuros to receive $2 million milestone payment from Checkmate Pharmaceuticals
Press Release, 29 March 2021
Kuros Biosciences publishes invitation to the Annual General Meeting 2021
Press Release, 18 March 2021
Kuros Biosciences reports results for the full year 2020
Press Release, 10 March 2021
Kuros Biosciences to present at upcoming clinical and investor conferences